S.C. Centrele de Excelenta ARES S.R.L.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
S.C. Centrele de Excelenta ARES S.R.L. - overview
Established
2010
Location
Bucharest, -, Romania
Primary Industry
Healthcare
About
S. C. Centrele de Excelenta ARES S. R.
L. is a Romanian company focused on innovative cardiology solutions, offering personalized medical services and emotional support to enhance patient experiences during their treatment journeys. Founded in 2010 and headquartered in Bucharest, Romania, S. C.
Centrele de Excelenta ARES S. R. L. specializes in cardiology, particularly addressing severe aortic stenosis.
Oren Iancovici established the company to provide comprehensive cardiovascular care. The firm's investment landscape changed in July 2019 when Highlander Partners acquired a 51% majority stake, although financial terms were not disclosed. S. C.
Centrele de Excelenta ARES S. R. L. delivers innovative cardiology solutions through its MONZA ARES Helper service, which provides empathetic support to patients from initial inquiries to recovery.
The company also focuses on comprehensive cardiovascular care tailored to diverse patient demographics, ensuring high-quality medical support across various European markets. In the most recent fiscal year of 2023, S. C. Centrele de Excelenta ARES S.
R. L. reported a revenue of USD 6. 90 mn and an EBITDA of USD -108,783.
60, reflecting their financial activities and operational focus on patient-centric care. Moving forward, S. C. Centrele de Excelenta ARES S.
R. L. aims to develop new products designed to enhance patient care, although specific launch dates have yet to be announced. The company plans to expand its services into additional European markets, targeting key regions by 2025.
The funding received from Highlander Partners will support these initiatives and bolster the company's commitment to improving patient outcomes in the cardiology sector.
Current Investors
Highlander Partners
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Hospitals, Cardiology
Website
www.medicina-interventionala.ro
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
S.C. Centrele de Excelenta ARES S.R.L. - timeline of key events
S.C. Centrele de Excelenta ARES S.R.L. - financials
| Fiscal Year Ended | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|
| Revenue (USD) | - | - | - |
| % Revenue Growth (YoY) | - | - | - |
| EBITDA (USD) | - | - | - |
| Operating Income (USD) | - | - | - |
| Operating Margin | - | - | - |
| % EBITDA Margin | - | - | - |
| NET Income (USD) | - | - | - |
| % Net Margin | - | - | - |
S.C. Centrele de Excelenta ARES S.R.L. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | S.C. Centrele de Excelenta ARES S.R.L. | - |
Displaying 1 - 1 of 1
S.C. Centrele de Excelenta ARES S.R.L. - employee data
S.C. Centrele de Excelenta ARES S.R.L. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Board President. Owner | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.